Status:

COMPLETED

COVID-19 Genomic Sequencing for Nosocomial Outbreak Investigations

Lead Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborating Sponsors:

Fonds de la Recherche en Santé du Québec

Canadian Institutes of Health Research (CIHR)

Conditions:

COVID-19

Molecular Sequence Variation

Eligibility:

All Genders

18-100 years

Brief Summary

This is a tertiary care hospital-based prospective molecular epidemiology study in Montreal, Canada. When nosocomial transmission was suspected by local infection control teams' investigations, SARS-C...

Detailed Description

This study will include infected healthcare workers (HCW) and patients for whom a nosocomial infection in CHUM is suspected. The CHUM laboratory is responsible for COVID-19 diagnostic testing in all e...

Eligibility Criteria

Inclusion

  • Hospitalized in the institution during the study period
  • Healthcare workers in the institution during the study period

Exclusion

  • None

Key Trial Info

Start Date :

November 9 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2023

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT05411562

Start Date

November 9 2020

End Date

December 31 2023

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre Hospitalier de l'Université de Montréal

Montreal, Quebec, Canada